MacroGenics, Inc. (MGNX)
3.74
+0.19
(+5.35%)
USD |
NASDAQ |
Oct 09, 16:00
3.74
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Gross Profit Margin (Quarterly) : 97.84% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 97.84% |
| March 31, 2026 | 46.01% |
| December 31, 2025 | 71.33% |
| September 30, 2025 | 81.63% |
| June 30, 2025 | 72.24% |
| March 31, 2025 | 45.64% |
| December 31, 2024 | 61.02% |
| September 30, 2024 | 96.65% |
| June 30, 2024 | 57.08% |
| March 31, 2024 | 56.54% |
| December 31, 2023 | 80.76% |
| September 30, 2023 | 48.94% |
| June 30, 2023 | 69.63% |
| March 31, 2023 | 73.44% |
| December 31, 2022 | 93.13% |
| September 30, 2022 | 85.65% |
| June 30, 2022 | 79.70% |
| March 31, 2022 | 73.33% |
| December 31, 2021 | 72.44% |
| September 30, 2021 | 71.52% |
| June 30, 2021 | 90.89% |
| March 31, 2021 | 83.73% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
| March 31, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -222.4% |
| Return on Assets | -38.60% |
| Return on Invested Capital | -60.44% |
| Profit Margin (Quarterly) | -212.1% |
| Operating Margin (Quarterly) | -42.19% |
| Return on Net Operating Assets | -154.9% |